Innocan Pharma posts Q2 FY2026 revenue of US$5.25M (CAD 7.3M)
Innocan Pharma reported second quarter fiscal year 2026 revenue of US$5.25M (CAD 7.3M).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.